Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 832 | 0 | 0 | 0 | 0 |
| Cost of Goods | 339 | N/A | 0 | 0 | N/A |
| Gross Profit | 493 | N/A | N/A | N/A | N/A |
| Operating Expenses | 101,977 | 104,827 | 91,152 | 91,222 | 91,217 |
| Operating Income | -101,145 | -104,827 | -91,152 | -91,222 | -91,217 |
| Other Income | 6,371 | 6,243 | 6,893 | 8,432 | 340 |
| Pre-tax Income | -94,774 | -98,584 | -84,259 | -82,790 | -90,877 |
| Net Income Continuous | -94,774 | -98,584 | -84,259 | -82,790 | -90,877 |
| Net Income Discontinuous | N/A | 3,957 | -4,507 | -3,427 | 1,965,202 |
| Net Income | $-94,774 | $-94,627 | $-88,766 | $-86,217 | $1,874,325 |
| EPS Basic Total Ops | -1.74 | 2.57 | -1.56 | -1.41 | 26.95 |
| EPS Basic Continuous Ops | -1.74 | -1.75 | -1.48 | -1.36 | -1.31 |
| EPS Basic Discontinuous Ops | N/A | 4.33 | -0.08 | -0.06 | 28.26 |
| EPS Diluted Total Ops | -1.74 | 2.57 | -1.56 | -1.41 | 26.95 |
| EPS Diluted Continuous Ops | -1.74 | -1.75 | -1.48 | -1.36 | -1.31 |
| EPS Diluted Discontinuous Ops | N/A | 4.33 | -0.08 | -0.06 | 28.26 |
| EBITDA(a) | $-97,517 | $-101,002 | $-87,039 | $-87,114 | $-87,074 |